In silico genome-scale reconstruction and validation of the Staphylococcus aureus metabolic network

Biotechnology and Bioengineering

Volumn 92, Issue 7, 2005, Pages 850-864

  Heinemann, Matthias ^a   Kümmel, Anne ^a   Ruinatscha, Reto ^a   Panke, Sven ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Gene deletion; Genome scale metabolic network; Small colony variant; Staphylococcus aureus

Indexed keywords

ANTIBIOTICS; BIOSYNTHESIS; FERMENTATION; LIPIDS; METABOLISM; PHYSIOLOGICAL MODELS; PROTEINS;

ANAEROBIC RESPIRATION; GENE DELETION; GENOME-SCALE METABOLIC NETWORK; PATHOGEN; SMALL COLONY VARIANT; STAPHYLOCOCCUS AUREUS;

GENES;

GLYCAN; LIPID;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL METABOLISM; BACTERIAL STRAIN; BIOSYNTHESIS; GENE DELETION; STAPHYLOCOCCUS AUREUS; STOICHIOMETRY; BACTERIAL GENOME; BIOLOGICAL MODEL; BIOLOGY; GENETICS; METABOLISM;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

COMPUTATIONAL BIOLOGY; GENOME, BACTERIAL; MODELS, GENETIC; STAPHYLOCOCCUS AUREUS;

EID: 33644829256     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.20663     Document Type: Article

References (93)

1. Akesson M, Förster J, Nielsen J. 2004. Integration of gene expression data into genome-scale metabolic models. Metab Eng 6(4):285-293.
2. Alberty RA. 2000. Calculating apparent equilibrium constants of enzyme-catalyzed reactions at pH 7. Biochemical Education 28(1):12-17.
3. Angelichio MJ, Camilli A. 2002. In vivo expression technology. Infect Immun 70(12):6518-6523.
4. Arakawa H, Shimada A, Ishimoto N, Ito E. 1981. Occurrence of ribitol-containing lipoteichoic acid in Staphylococcus aureus H and its glycosylation. J Biochem 89(5):1555-1563.
5. Baddiley J. 1989. Bacterial cell walls and membranes-Discovery of the teichoic acids. Bioessays 10(6):207-210.
6. Becker SA, Palsson BO. 2005. Genome-scale reconstruction of the metabolic network in Staphylococcus aureus N315: An initial draft to the two-dimensional annotation. BMC Microbiology 5:8.
7. Blumenthal HJ. 1972. Glucose catabolism in staphylococci. In: Cohen JO, editor. Staphylococci. New York: Interscience, p 111-135.
8. Bronner S, Monteil H, Prevost G. 2004. Regulation of virulence determinants in Staphylococcus aureus: Complexity and applications. FEMS Microbiology Reviews 28(2):183-200.
9. Burgard AP, Maranas CD. 2003. Optimization-based framework for inferring and testing hypothesized metabolic objective functions. Biotechnol Bioeng 82(6):670-677.
10. Burke KA, Lascelles J. 1975. Nitrate reductase system in Staphylococcus aureus wild type and mutants. J Bacteriol 123(1):308-316.
11. Burke KA, Lascelles J. 1979. Partial purification and some properties of the Staphylococcus aureus cytoplasmic nitrate reductase. J Bacteriol 139(1):120-125.
12. Burke KA, Brown AE, Lascelles J. 1981. Membrane and cytoplasmic nitrate reductase of Staphylococcus aureus and application of crossed immunoelectrophoresis. J Bacteriol 148(2):724-727.
13. Chen SL. 1964. Energy requirement for microbial growth. Nature 202(493):1135-1136.
14. Christian JHB, Waltho JA. 1964. The composition of Staphylococcus aureus in relation to the water activity to the growth medium. J Gen Microbiol 35:205-213.
15. Cordwell SJ, Larsen MR, Cole RT, Walsh BJ. 2002. Comparative proteomics of Staphylococcus aureus and the response of methicillin-resistant and methicillin-sensitive strains to Triton X-100. Microbiology 148:2765-2781.
16. Covert MW, Knight EM, Reed JL, Herrgard MJ, Palsson BO. 2004. Integrating high-throughput and computational data elucidates bacterial networks. Nature 429(6987):92-96.
17. Cui LZ, Murakami H, Kuwahara-Arai K, Hanaki H, Hiramatsu K. 2000. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob Agents Chemother 44(9):2276-2285.
18. Dunman PM, Mounts W, McAleese F, Immermann F, Macapagal D, Marsilio E, McDougal L, Tenover FC, Bradford PA, Petersen PJ, Projan SJ, Murphy E. 2004. Uses of Staphylococcus aureus GeneChips in genotyping and genetic composition analysis. J Clin Microbiol 42(9):4275-4283.
19. Förster J, Famili I, Fu P, Palsson BO, Nielsen J. 2003. Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network. Genome Res 13(2):244-253.
20. Garrard W, Lascelle J. 1968. Regulation of Staphylococcus aureus lactate dehydrogenase. J Bacteriol 95(1):152.
21. Gladstone GP. 1937. The nutrition of Staphylococcus aureus: Nitrogen requirements. Br J Exp Pathol 18:322-333.
22. Graham JE, Wilkinson BJ. 1992. Staphylococcus aureus osmoregulation-roles for choline, glycine betaine, proline, and taurine. J Bacteriol 174(8):2711-2716.
23. Gutberlet T, Dietrich U, Bradaczek H, Pohlentz G, Leopold K, Fischer W. 2000. Cardiolipin, alpha-D-glucopyranosyl, and L-lysylcardiolipin from gram-positive bacteria: FAB MS, monofilm and X-ray powder diffraction studies. Biochim Biophys Acta 1463(2):307-322.
24. Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum R, Labischinski H, Hiramatsu K. 1998. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother 42(2):199-209.
25. Hancock R. 1960. The amino acid composition of the protein and cell wall of Staphylococcus aureus. Biochim Biophys Acta 37(1):42-46.
26. Harrington C, Baddiley J. 1985. Biosynthesis of wall teichoic acids in Staphylococcus aureus H, Micrococcus varians and Bacillus subtilis W23. Involvement of lipid intermediates containing the disaccharide N-acetylmannosaminyl N-acetylglucosamine. Eur J Biochem 153(3):639-645.
27. Hecker M, Engelmann S, Cordwell SJ. 2003. Proteomics of Staphylococcus aureus-Current state and future challenges. J Chromatogr B 787(1):179-195.
28. Hugo WB, Davidson JR. 1973. Effect of cell lipid depletion in Staphylococcus aureus upon its resistance to antimicrobial agents. 1. Lipid depletion induced by biotin deficiency. Microbios 8(29):43-51.
29. Iliopoulos I, Tsoka S, Andrade M, Janssen P, Audit B, Tramontano A, Valencia A, Leroy C, Sander C, Ouzounis C. 2000. Genome sequences and great expectations. Genome Biol 2(1): (Interactions 0001.1).
30. Ingraham JL, Maaløe O, Neidhardt FC. 1983. Growth of the bacterial cell: Sunauer Associates, Inc.
31. Ito E, Strominger JL. 1962. Enzymatic synthesis of peptide in bacterial uridine nucleotides. 1. Enzymatic addition of L-alanine, D-glutamic acid, and L-lysine. J Biol Chem 237(8):2689-2695.
32. Jana M, Luong T-T, Komatsuzawa H, Shigeta M, Lee CY. 2000. A method for demonstrating gene essentiality in Staphylococcus aureus. Plasmid 44(1):100-104.
33. Ji Y, Zhang B, Van Horn SF, Warren P, Woodnutt G, Burnham MKR, Rosenberg M. 2001. Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. Science 293(5538):2266-2269.
34. Jiang WP, Hermolin J, Fillingame RH. 2001. The preferred stoichiometry of c subunits in the rotary motor sector of Escherichia coli ATP synthase is 10. Proc Natl Acad Sci U S A 98(9):4966-4971.
35. Jolly L, Wu S, van Heijenoort J, de Lencastre H, Mengin-Lecreulx D, Tomasz A. 1997. The femR315 gene from Staphylococcus aureus, the interruption of which results in reduced methicillin resistance, encodes a phosphoglucosamine mutase. J Bacteriol 179(17):5321-5325.
36. Kashket ER. 1981. Proton motive force in growing Streptococcus lactis and Staphylococcus aureus cells under aerobic and anaerobic conditions. J Bacteriol 146(1):369-376.
37. Kiriukhin MY, Neuhaus FC. 2001. D-alanylation of lipoteichoic acid: Role of the D-alanyl carrier protein in acylation. J Bacteriol 183(6):2051-2058.
38. Koch HU, Haas R, Fischer W. 1984. The role of lipoteichoic acid biosynthesis in membrane lipid-metabolism of growing Staphylococcus aureus. Eur J Biochem 138(2):357-363.
39. Kohler C, von Eiff C, Peters G, Proctor RA, Hecker M, Engelmann S. 2003. Physiological characterization of a heme-deficient mutant of Staphylococcus aureus by a proteomic approach. J Bacteriol 185(23):6928-6937.
40. Kubak BM, Yotis WW. 1981. Analysis of Staphylococcus aureus cytoplasmic membrane proteins by isoelectric focusing. Biochim Biophys Acta 649:642-650.
41. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki K-i, Nagai Y. 2001. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357(9264):1225-1240.
42. Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K. 2003. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol 49(3):807-821.
43. Lascelles J. 1979. Heme-deficient mutants of Staphylococcus aureus. Methods Enzymol p 172-178.
44. Lascelles J, Burke KA. 1978. Reduction of ferric iron by L-lactate and DL-glycerol-3-phosphate in membrane preparations from Staphylococcus aureus and interactions with nitrate reductase system. J Bacteriol 134(2):585-589.
45. Lowy FD. 2003. Antimicrobial resistance: The example of Staphylococcus aureus. J Clin Invest 111(9):1265-1273.
46. Mahadevan R, Schilling CH. 2003. The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. Metab Eng 5:264-276.
47. McNamara PJ, Proctor RA. 2000. Staphylococcus aureus small colony variants, electron transport and persistent infections. Int J Antimicrob Agents 14(2):117-122.
48. Miller RD, Fung DYC. 1973. Amino acid requirements for production of enterotoxin-B by Staphylococcus aureus S-6 in a chemically defined medium. Appl Microbiol 25(5):800-806.
49. Miller KJ, Zeit SC, Bae JH. 1991. Glycine betaine and proline are the principal compatible solutes of Staphylococcus aureus. Curr Microbiol 23(3):131-137.
50. Navarre WW, Schneewind O. 1999. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev 63(1):174-229.
51. Neuhaus FC, Baddiley J. 2003. A continuum of anionic charge: Structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol Mol Biol Rev 67(4):686-723.
52. Novick RP. 2003. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48(6):1429-1449.
53. O'Leary WM, Wilkinson SG. 1988. Gram-positive bacteria. In: Ratledge C, Wilkinson SG, editors. Microbial lipids. London: Academic Press. p 117-201.
54. Papin JA, Stelling J, Price ND, Klamt S, Schuster S, Palsson BO. 2004. Comparison of network-based pathway analysis methods. Trends Biotechnol 22(8):400-405.
55. Patil KR, Akesson M, Nielsen J. 2004. Use of genome-scale microbial models for metabolic engineering. Curr Opin Biotechnol 15(1):64-69.
56. Pechous R, Ledala N, Wilkinson BJ, Jayaswal RK. 2004. Regulation of the expression of cell wall stress stimulon member gene msrA1 in methicillin-susceptible or-resistant Staphylococcus aureus. Antimicrob Agents Chemother 48(8):3057-3063.
57. Perego M, Glaser P, Minutello A, Strauch MA, Leopold K, Fischer W. 1995. Incorporation of D-alanine into lipoteichoic acid and wall teichoic acid in Bacillus subtilis-Identification of genes and regulation. J Biol Chem 270(26):15598-15606.
58. Pereira MP, Brown ED. 2004. Bifunctional catalysis by CDP-ribitol synthase: Convergent recruitment of reductase and cytidylyltransferase activities in Haemophilus influenzae and Staphylococcus aureus. Biochemistry 43(37):11802-11812.
59. Perry AM, Ton-That H, Mazmanian SK, Schneewind O. 2002. Anchoring of surface proteins to the cell wall of Staphylococcus aureus. III. Lipid II is an in vivo peptidoglycan substrate for sortase-catalyzed surface protein anchoring. J Biol Chem 277(18):16241-16248.
60. Pramanik J, Keasling JD. 1997. Stoichiometric model of Escherichia coli metabolism: Incorporation of growth-rate dependent biomass composition and mechanistic energy requirements. Biotechnol Bioeng 56(4):398-421.
61. Pramanik J, Keasling JD. 1998. Effect of Escherichia coli biomass composition on central metabolic fluxes predicted by a stoichiometric model. Biotechnol Bioeng 60(2):230-238.
62. Price ND, Papin JA, Schilling CH, Palsson BO. 2003. Genome-scale microbial in silica models: The constraints-based approach. Trends in Biotechnology 21(4):162-169.
63. Proctor RA, Balwit JM, Vesga O. 1994. Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect Agents Dis 3:302-312.
64. Reed JL, Vo TD, Schilling CH, Palsson BO. 2003. An expanded genome-scale model of Escherichia coli K12 (iJR904 GSM/GPR). Genome Biol 4(9):R54.
65. Reusch VM, Jr. 1984. Lipopolymers, isoprenoids, and the assembly of the gram-positive cell wall. CRC Crit Rev Microbiol 11:129-155.
66. Sasarman A, Purvis P, Portelan V. 1974. Role of menaquinone in nitrate respiration in Staphylococcus aureus. J Bacteriol 117(2):911-913.
67. Schilling CH, Covert MW, Famili I, Church GM, Edwards JS, Palsson BO. 2002. Genome-scale metabolic model of Helicobacter pylori 26695. J Bacteriol 184(16):4582-4593.
68. Schleifer KH, Kandler O. 1972. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriology Reviews 36:407-477.
69. Sehnalova H, Dadak V. 1976. The influence of MK on the activity of dehydrogenases of Staphylococcus epidermidis. Scripta Facultatis Scientiarum Naturalium Universitatis Purkynianae Brunensis 6:97-102.
70. Sieradzki K, Tomasz A. 1999. Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus. J Bacteriol 181(24):7566-7570.
71. Somerville GA, Chaussee MS, Morgan CI, Fitzgerald JR, Dorward DW, Reitzer LJ, Musser JM. 2002. Staphylococcus aureus aconitase inactivation unexpectedly inhibits post-exponential-phase growth and enhances stationary-phase survival. Infect Immun 70(11):6373-6382.
72. Somerville GA, Said-Salim B, Wickman JM, Raffel SJ, Kreiswirth BN, Musser JM. 2003. Correlation of acetate catabolism and growth yield in Staphylococcus aureus: Implications for host-pathogen interactions. Infect Immun 71(8):4724-4732.
73. Stelling J, Klamt S, Bettenbrock K, Schuster S, Gilles ED. 2002. Metabolic network structure determines key aspects of functionality and regulation. Nature 420(6912):190-193.
74. Stephanopoulos G, Aristidou AA, Nielsen J. 1998. Metabolic engineering. Principles and methodologies. San Diego: Academic Press.
75. Sutcliffe IC, Shaw N. 1991. Atypical lipoteichoic acids of gram-positive bacteria. J Bacteriol 173:7065-7069.
76. Tempest DW, Neijssel OM. 1984. The status of YATP and maintenance energy as biologically interpretable phenomena. Annu Rev Microbiol 38:459-486.
77. Throup JP, Zappacosta F, Lunsford RD, Annan RS, Carr SA, Lonsdale JT, Bryant AP, McDevitt D, Rosenberg M, Burnham MKR. 2001. The srhSR gene pair from Staphylococcus aureus: Genomic and proteomic approaches to the identification and characterization of gene function. Biochemistry 40(34):10392-10401.
78. Tomasz A. 2000. The staphylococcal cell wall. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI, editors. Gram-positive pathogens. Washington, DC: ASM Press, p 351-360.
79. Tynecka Z. 1968. Free amino acids of staphylococci. Exper Med Microbiol 20(3):227-232.
80. Tynecka Z, Malm A. 1996. Cadmium-sensitive targets in the aerobic respiratory metabolism of Staphylococcus aureus. J Basic Microbiol 36(6):447-452.
81. Tynecka Z, Szczesniak Z, Malm A, Los R. 1999. Energy conservation in aerobically grown Staphylococcus aureus. Res Microbiol 150(8):555-566.
82. Varma A, Boesch BW, Palsson BO. 1993. Stoichiometric interpretation of Escherichia coli glucose catabolism under various oxygenation rates. Appl Environ Microbiol 59(8):2465-2473.
83. Vinnikov AI. 1988. ATP synthesis in S. aureus cells during the induction of membrane potential and proton gradient. Biokhimiya (Moscow) 53(5):853-855.
84. von Eiff C, Heilmann C, Proctor RA, Woltz C, Peters G, Götz F. 1997. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol 179(15):4706-4712.
85. Ward JB, Perkins HR. 1968. The chemical composition of membranes of protoplasts and L-forms of Staphylococcus aureus. Biochem J 106(2):391-400.
86. Weerkamp A, Heinenvonborries UJ, Vogels GD. 1978. Biochemical and ultrastructural changes in Staphylococcus aureus treated with staphylococcin 1580. Antonie Van Leeuwenhoek J Microbiol 44(1):35-48.
87. Weidel W, Pelzer H. 1964. Bagshaped macromolecules-A new outlook on bacterial cell walls. Adv Enzymol 26:192-232.
88. White DC, Frerman FE. 1967. Extraction, characterization, and cellular localization of the lipids of Staphylococcus aureus. J Bacteriol 94(6):1854-1867.
89. Wilding EI, Kim D-Y, Bryant AP, Gwynn MN, Lunsford RD, McDevitt D, Myers JE, Jr., Rosenberg M, Sylvester D, Stauffacher CV, Rodwell WW, 2000. Essentiality, expression, and characterization of the class II 3-hydroxy-3-methylglutaryl coenzyme A reductase of Staphylococcus aureus. J. Bacteriol 182(18):5147-5152.
90. Wilkinson BJ. 1997. Biology. In: Crossley KB, Archer GL, editors. The staphylococci in human disease. New York: Churchill Livingstone. p 1-38.
91. Wiltshire MD, Foster SJ. 2001. Identification and analysis of Staphylococcus aureus components expressed by a model system of growth in serum. Infect Immun 69(8):5198-5202.
92. Witte W. 1999. Antibiotic resistance in gram-positive bacteria: Epidemiological aspects. J Antimicrob Chemother 44(90001):1-9.
93. Wu C-H, Bergdoll MS. 1971. Stimulation of enterotoxin B production. Infect Immun 3(6):784-792.